Pharmacogentics And Cancer Susceptibility Flashcards

1
Q

Define monogenic

A

Caused by a single gene which results in disease w very high probability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Define polygenic

A

Serval or numerous genes involved which are inherited by the same individual
Each individual gene confers a small increase in risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe how monogenic and polygenic vary in penetrance and population therapy

A

Mono: low frequency but high penetrance for disease
Poly: high frequency but low penetrance for disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe the polygenic disease model

A

Penetrance with each individual gene despite each gene having a low penetrance allele

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe AML as a monogenic disease

A

High penetrance variants are rare
Some genes are mutated soamtically
Recurrence is strong evidence of functionality

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe the approach to identify monogenic disease

A

Family studies using linkage of microsatellite markers
Exome sequencing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe the approaches to identify polygenic disease

A

Case control association studies
Candidate gene association or e genome wide association study using unrelated individuals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

When are case-control studies used

A

Determine the risk of disease development by comparing frequency of genetic trait in cases and appropriately matched controls

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the odds ratio

A

Ratio of odds of exposure to non exposure among disease compared to non diseases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How to calculate odds ratio

A

OR = A x D / B x D

Assess significance of OR
Calculate 95% confidence using X2 analysis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is genome wide association studies

A

Genotype for 500,00 to 1,000,000 SNPs scattered throughout human genome in a group of cases vs group of controls

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is imputation

A

Strong linkage disequilibrium in human genome allows accurate prediction of neighbouring SNPs that haven’t been directly genotype

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the limitations of using case-control studies

A

Increases risk of obtaining false-positives associations Cases may be different genetically due to ethnicity
Data needs to be carefully cleaned
Good information needed on disease phenotype and environmental risk factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How can case-control studies ensure that the association is genuine

A

Need to replicate a significant finding in several groups

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Name some cancers due to a single gene defect

A

BRCA1/2 in breast cancers
MLH1 mismatch repair gene in colon cancer
TP53 associated w susceptibility to particularly cancers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What genetic components that are common in almost all cancers with polygenic effects

A

Xenobiotic biotransformation genoptype
DNA repair genes

17
Q

What are common sources of carcinogens

A

Tobacco smoke
Food
Occupational exposure
Cellular processes

18
Q

Describe how GWAS data has helped in identifying breast cancer risk genes

A

> 70 genes now identified including FGFR2, TNRC9 and MAP3K1
Difference in distribution between cases and controls shown
Does not exclude role for pharmacogenetic polymorphisms

19
Q

How many loci show genome wide signifance in lung cancer

A

18

20
Q

How many loci carrying common variants have been identified using GWAS in CLL

A

> 45 that’s count for 25% of the heritable risk of CLL

21
Q

What is the link between CYP2A6 and lung cancers susceptibility

A

Confirmed risk factor for lung cancer
Allele: *4
One or more variant CYP2A6 alleles protects against lung cancer

22
Q

Describe HLA

A

Located in 6p21.3 and many of the genes encode immune system proteins

Antigens on specialised immune cells present peptides from foreign substances to effector cells

23
Q

How many human cancers are caused by infection

A

1 in 7

HPV = cervical cancer
Hep B and Hep C = liver cancer

24
Q

What defines the outcome (risk)

A

Interactions between genes and exposure

25
Q

How do somatic mutations occur

A

CH3 group is added onto the O
Mismatch: instead of G + C it’s actually G + T

26
Q

Describe how a mismatch due to a methyl group is fixed

A

Excises the T has been inserted
Attempts to replace with a C but methyl group is still present so T is readded

End up with strand breakage = cell death

27
Q

What happens if a cancer cell loses its ability for strand mismatch repair

A

Lose the ability to die, stay as mutation and drive colon cancer risk

28
Q

Describe the MLH1 mutation

A

G>A position -93
Affects levels of MLH1 txn and protein levels
= not fully competent for mismatch repair

Approx 15% mutation and slightly increased risk of colon cancer

29
Q

What is the link between methylating agents and leukaemia

A

Risk factor for this who were treated w chemotherapeutic methylating agents in first cancer
Often Hodgkin’s lymphoma